ea0077op6.1 | Endocrine Cancer and Late Effects | SFEBES2021
Garrahy Aoife
, Tadman Mike
, Slater Viv
, Moore Niall
, Coupe Nicholas
, Weaver Andrew
, Soonawalla Zahir
, Patel Neel
, May Christine
, Jafar Mohammadi Bahram
Gallium68-Dotatate PET-CT is a somatostatin-receptor (SSTR) based imaging modality employed in the diagnosis and follow-up of Neuroendocrine Tumours (NET). We set out to investigate the incidence of incidental findings, some of which are related to SSTR expression, in our NET patient cohort in Oxford University Hospital. Sixty-eight patients underwent Gallium68-Dotatate PET-CT between June 2020 and June 2021. 40 patients (59%) were female, and median age ...